Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.047 SGD | +9.30% | +11.90% | +4.44% |
Mar. 12 | Singaporean Shares End Marginally Higher; Biopharma's Shares Climb 2% on Introduction of New Sublingual Wafer | MT |
Mar. 12 | IX Biopharma Introduces New Sublingual Wafer | MT |
Sales 2022 | 14.39M 10.66M | Sales 2023 | 5.91M 4.38M | Capitalization | 69.73M 51.68M |
---|---|---|---|---|---|
Net income 2022 | -4M -2.96M | Net income 2023 | -9M -6.67M | EV / Sales 2022 | 7.87 x |
Net cash position 2022 | 9.18M 6.81M | Net cash position 2023 | 2.2M 1.63M | EV / Sales 2023 | 11.4 x |
P/E ratio 2022 |
-26.3
x | P/E ratio 2023 |
-7.22
x | Employees | 45 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 49.01% |
1 day | +9.30% | ||
1 week | +11.90% | ||
Current month | +9.30% | ||
1 month | -6.00% | ||
3 months | +11.90% | ||
6 months | +11.90% | ||
Current year | +4.44% |
Managers | Title | Age | Since |
---|---|---|---|
Yip Hang Lee
CEO | Chief Executive Officer | - | 04-05-07 |
Sien Lup Chew
DFI | Director of Finance/CFO | 60 | 16-04-13 |
Chief Operating Officer | 45 | 16-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Yip Hang Lee
CEO | Chief Executive Officer | - | 04-05-07 |
Shing Tung Ho
BRD | Director/Board Member | 57 | 13-02-28 |
Patrick Davies
BRD | Director/Board Member | 57 | 19-12-01 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-02 | 0.047 | +9.30% | 600 |
24-04-29 | 0.043 | +2.38% | 20,000 |
24-04-26 | 0.042 | +2.44% | 20,000 |
Delayed Quote Singapore S.E., May 02, 2024 at 04:45 am EDT
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+4.44% | 26.76M | |
+21.85% | 546B | |
-4.77% | 359B | |
+16.97% | 323B | |
+5.69% | 290B | |
+13.68% | 234B | |
+3.65% | 198B | |
-11.12% | 194B | |
+8.08% | 167B | |
-3.40% | 157B |
- Stock Market
- Equities
- 42C Stock